Keep Us Strong WikiLeaks logo

Currently released so far... 97115 / 251,287

Articles

Browse latest releases

Browse by creation date

Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z

Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ETRD EAGR ETTC EAID ECON EFIN ECIN EINV ELAB EAIR ENRG EPET EWWT ECPS EIND EMIN ELTN EC ETMIN EUC EZ ET ELECTIONS ENVR EU EUN EG EINT ER ECONOMICS ES EMS ENIV EEB EN ECE ECOSOC EK ENVIRONMENT EFIS EI EWT ENGRD ECPSN EXIM EIAD ERIN ECPC EDEV ENGY ECTRD EPA ESTH ECCT EINVECON ENGR ERTD EUR EAP EWWC ELTD EL EXIMOPIC EXTERNAL ETRDEC ESCAP ECO EGAD ELNT ECONOMIC ENV ETRN EIAR EUMEM ENRGPARMOTRASENVKGHGPGOVECONTSPLEAID EREL ECOM ECONETRDEAGRJA ETCC ETRG ECONOMY EMED ETR ENERG EITC EFINOECD EURM EENG ERA EXPORT ENRD ECONEINVETRDEFINELABETRDKTDBPGOVOPIC EGEN EBRD EVIN ETRAD ECOWAS EFTA ECONETRDBESPAR EGOVSY EPIN EID ECONENRG EDRC ESENV ETT EB ENER ELTNSNAR ECHEVARRIA ETRC EPIT EDUC ESA EFI ENRGY ESCI EE EAIDXMXAXBXFFR EETC ECIP EIAID EIVN EBEXP ESTN EING EGOV ETRA EPETEIND ELAN ETRDGK EAIDRW ETRDEINVECINPGOVCS EPEC ENVI ELN EAG EPCS EPRT EPTED ETRB EUM EAIDS EFIC EFINECONEAIDUNGAGM EAIDAR ESF EIDN ELAM EDU EV EAIDAF ECN EDA EXBS EINTECPS ENRGTRGYETRDBEXPBTIOSZ EPREL EAC EINVEFIN ETA EAGER EINDIR ECA ECLAC ELAP EITI EUCOM ECONEFINETRDPGOVEAGRPTERKTFNKCRMEAID EARG ELDIN EINVKSCA ENNP EFINECONCS EFINTS ECCP ETC EAIRASECCASCID EINN ETRP EAIDNI EFQ ECOQKPKO EGPHUM EBUD ECONEINVEFINPGOVIZ ENERGY ELB EINDETRD EMI ECONEFIN EIB EURN ETRDEINVTINTCS EIN EFIM ETIO ELAINE EMN EATO EWTR EIPR EINVETC ETTD ETDR EIQ ECONCS EPPD ENRGIZ EISL ESPINOSA ELEC EAIG ESLCO EUREM ENTG ERD EINVECONSENVCSJA EEPET EUNCH ECINECONCS ETRO ETRDECONWTOCS ECUN EFND EPECO EAIRECONRP ERGR ETRDPGOV ECPN ENRGMO EPWR EET EAIS EAGRE EDUARDO EAGRRP EAIDPHUMPRELUG EICN ECONQH EVN EGHG ELBR EINF EAIDHO EENV ETEX ERNG ED
KMDR KPAO KPKO KJUS KCRM KGHG KFRD KWMN KDEM KTFN KHIV KGIC KIDE KSCA KNNP KHUM KIPR KSUM KISL KIRF KCOR KRCM KPAL KWBG KN KS KOMC KSEP KFLU KPWR KTIA KSEO KMPI KHLS KICC KSTH KMCA KVPR KPRM KE KU KZ KFLO KSAF KTIP KTEX KBCT KOCI KOLY KOR KAWC KACT KUNR KTDB KSTC KLIG KSKN KNN KCFE KCIP KGHA KHDP KPOW KUNC KDRL KV KPREL KCRS KPOL KRVC KRIM KGIT KWIR KT KIRC KOMO KRFD KUWAIT KG KFIN KSCI KTFIN KFTN KGOV KPRV KSAC KGIV KCRIM KPIR KSOC KBIO KW KGLB KMWN KPO KFSC KSEAO KSTCPL KSI KPRP KREC KFPC KUNH KCSA KMRS KNDP KR KICCPUR KPPAO KCSY KTBT KCIS KNEP KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KNNB KGCC KINR KPOP KMFO KENV KNAR KVIR KDRG KDMR KFCE KNAO KDEN KGCN KICA KIMMITT KMCC KLFU KMSG KSEC KUM KCUL KMNP KSMT KCOM KOMCSG KSPR KPMI KRAD KIND KCRP KAUST KWAWC KTER KCHG KRDP KPAS KITA KTSC KPAOPREL KWGB KIRP KJUST KMIG KLAB KTFR KSEI KSTT KAPO KSTS KLSO KWNN KPOA KHSA KNPP KPAONZ KBTS KWWW KY KJRE KPAOKMDRKE KCRCM KSCS KWMNCI KESO KWUN KPLS KIIP KEDEM KPAOY KRIF KGICKS KREF KTRD KFRDSOCIRO KTAO KJU KWMNPHUMPRELKPAOZW KEN KO KNEI KEMR KKIV KEAI KWAC KRCIM KWCI KFIU KWIC KCORR KOMS KNNO KPAI KBWG KTTB KTBD KTIALG KILS KFEM KTDM KESS KNUC KPA KOMCCO KCEM KRCS KWBGSY KNPPIS KNNPMNUC KWN KERG KLTN KALM KCCP KSUMPHUM KREL KGH KLIP KTLA KAWK KWMM KVRP KVRC KAID KSLG KDEMK KX KIF KNPR KCFC KFTFN KTFM KPDD KCERS KMOC KDEMAF KMEPI KEMS KDRM KEPREL KBTR KEDU KNP KIRL KNNR KMPT KISLPINR KTPN KA KJUSTH KPIN KDEV KTDD KAKA KFRP KWNM KTSD KINL KJUSKUNR KWWMN KECF KWBC KPRO KVBL KOM KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KEDM KFLD KLPM KRGY KNNF KICR KIFR KM KWMNCS KAWS KLAP KPAK KDDG KCGC KID KNSD KMPF KPFO KDP KCMR KRMS KNPT KNNNP KTIAPARM KDTB KNUP KPGOV KNAP KNNC KUK KSRE KREISLER KIVP KQ KTIAEUN KPALAOIS KRM KISLAO KWM KFLOA
PHUM PINR PTER PGOV PREL PREF PL PM PHSA PE PARM PINS PK PUNE PO PALESTINIAN PU PBTS PROP PTBS POL POLI PA PGOVZI POLMIL POLITICAL PARTIES POLM PD POLITICS POLICY PAS PMIL PINT PNAT PV PKO PPOL PERSONS PING PBIO PH PETR PARMS PRES PCON PETERS PRELBR PT PLAB PP PAK PDEM PKPA PSOCI PF PLO PTERM PJUS PSOE PELOSI PROPERTY PGOVPREL PARP PRL PNIR PHUMKPAL PG PREZ PGIC PBOV PAO PKK PROV PHSAK PHUMPREL PROTECTION PGOVBL PSI PRELPK PGOVENRG PUM PRELKPKO PATTY PSOC PRIVATIZATION PRELSP PGOVEAIDUKNOSWGMHUCANLLHFRSPITNZ PMIG PREC PAIGH PROG PSHA PARK PETER POG PHUS PPREL PS PTERPREL PRELPGOV POV PKPO PGOVECON POUS PGOVPRELPHUMPREFSMIGELABEAIDKCRMKWMN PWBG PMAR PREM PAR PNR PRELPGOVEAIDECONEINVBEXPSCULOIIPBTIO PARMIR PGOVGM PHUH PARTM PN PRE PTE PY POLUN PPEL PDOV PGOVSOCI PIRF PGOVPM PBST PRELEVU PGOR PBTSRU PRM PRELKPAOIZ PGVO PERL PGOC PAGR PMIN PHUMR PVIP PPD PGV PRAM PINL PKPAL PTERE PGOF PINO PHAS PODC PRHUM PHUMA PREO PPA PEPFAR PGO PRGOV PAC PRESL PORG PKFK PEPR PRELP PREFA PNG PGOVPHUMKPAO PRELECON PINOCHET PFOR PGOVLO PHUMBA PRELC PREK PHUME PHJM POLINT PGOVPZ PGOVKCRM PGOVE PHALANAGE PARTY PECON PEACE PROCESS PLN PRELSW PAHO PEDRO PRELA PASS PPAO PGPV PNUM PCUL PGGV PSA PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PGIV PRFE POGOV PEL PBT PAMQ PINF PSEPC POSTS PHUMPGOV PVOV PHSAPREL PROLIFERATION PENA PRELTBIOBA PIN PRELL PGOVPTER PHAM PHYTRP PTEL PTERPGOV PHARM PROTESTS PRELAF PKBL PRELKPAO PKNP PARMP PHUML PFOV PERM PUOS PRELGOV PHUMPTER PARAGRAPH PERURENA PBTSEWWT PCI PETROL PINSO PINSCE PQL PEREZ PBS

Browse by classification

Community resources

courage is contagious

Viewing cable 08RANGOON279, BURMA: LACK OF TB DRUGS A LOOMING PROBLEM

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs

Understanding cables
Every cable message consists of three parts:
  • The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
  • The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
  • The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.
To understand the justification used for the classification of each cable, please use this WikiSource article as reference.

Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #08RANGOON279.
Reference ID Created Released Classification Origin
08RANGOON279 2008-04-22 10:38 2011-08-25 00:00 UNCLASSIFIED//FOR OFFICIAL USE ONLY Embassy Rangoon
VZCZCXRO4415
RR RUEHCHI RUEHDT RUEHHM RUEHLN RUEHMA RUEHNH RUEHPB RUEHPOD
DE RUEHGO #0279/01 1131038
ZNR UUUUU ZZH
R 221038Z APR 08
FM AMEMBASSY RANGOON
TO RUEHC/SECSTATE WASHDC 7415
RUCNASE/ASEAN MEMBER COLLECTIVE
RUEHZN/ENVIRONMENT SCIENCE COLLECTIVE
RUEHBJ/AMEMBASSY BEIJING 1817
RUEHBY/AMEMBASSY CANBERRA 1068
RUEHKA/AMEMBASSY DHAKA 4826
RUEHLO/AMEMBASSY LONDON 2015
RUEHNE/AMEMBASSY NEW DELHI 4616
RUEHUL/AMEMBASSY SEOUL 8156
RUEHTC/AMEMBASSY THE HAGUE 0669
RUEHKO/AMEMBASSY TOKYO 5717
RUEHRO/AMEMBASSY ROME 0153
RUEHFR/AMEMBASSY PARIS 0572
RUEHCN/AMCONSUL CHENGDU 1420
RUEHCHI/AMCONSUL CHIANG MAI 1510
RUEHCI/AMCONSUL KOLKATA 0278
RUEAUSA/DEPT OF HHS WASHDC
RHHMUNA/CDR USPACOM HONOLULU HI
RUEHPH/CDC ATLANTA GA
RUCLRFA/USDA WASHDC
RUEHRC/USDA FAS WASHDC
RHEHNSC/NSC WASHDC
RUCNDT/USMISSION USUN NEW YORK 1471
RUEKJCS/SECDEF WASHDC
RUEHBS/USEU BRUSSELS
RUEKJCS/JOINT STAFF WASHDC
UNCLAS SECTION 01 OF 04 RANGOON 000279 
 
SIPDIS 
 
SENSITIVE 
SIPDIS 
 
DEPT FOR EAP/EX; EAP/MLS; EAP/EP; EAP/PD 
DEPT FOR OES/STC/MGOLDBERG AND PBATES; OES/PCI/ASTEWART; 
OES/IHA/DSINGER AND NCOMELLA 
DEPT PASS TO USAID/ANE/CLEMENTS AND GH/CARROLL 
CDC ATLANTA FOR COGH SDOWELL and NCID/IB AMOEN 
USDA FOR OSEC AND APHIS 
USDA FOR FAS/DLP/HWETZEL AND FAS/ICD/LAIDIG 
USDA/FAS FOR FAA/YOUNG, MOLSTAD, ICD/PETTRIE, ROSENBLUM 
DOD FOR OSD/ISA/AP FOR LEW STERN 
PARIS FOR FAS/AG MINISTER COUNSELOR/OIE 
ROME FOR FAO 
BANGKOK FOR REO OFFICE, USAID/RDMA HEALTH OFFICE - JMACARTHUR, 
CBOWES 
TOKYO FOR HEALTH OFFICER 
PACOM FOR FPA 
 
E.O. 12958:N/A 
TAGS: ECON TBIO EAID SOCI PGOV AMED BM
SUBJECT: BURMA: LACK OF TB DRUGS A LOOMING PROBLEM 
 
REF: A) RANGOON 278   B) 07 RANGOON 1027   C) 07 RANGOON 1120 
 
RANGOON 00000279  001.2 OF 004 
 
 
1.  (SBU)  Summary.  Burma is one of 22 tuberculosis high-burden 
countries in the world.  The Government's National TB Program (NTP), 
 active in all of Burma's 324 townships, reported a case detection 
rate of 95 percent of all infectious cases and had a treatment rate 
of 83.6 percent in 2006.  The backbone of Burma's NTP is the 
availability of free first line drugs for 150,000 cases, provided 
free of charge from the Global Drug Facility (GDF).  However, GDF's 
commitment for free drugs will end in 2009, leaving Burma with no 
drugs to combat the second deadliest disease in the country.  The 
lack of TB drugs poses a huge challenge for TB infection control in 
Burma, and health experts predict that TB incidence rates, including 
multi-drug resistant and extremely drug resistant TB, will increase 
exponentially after 2009.  The GOB is considering applying for Round 
9 Global Fund assistance for 2011, but even if the Global Fund 
commits to providing TB drugs to Burma, there will still be a 
two-year gap in drug availability.  The Japanese Government is 
considering filling this gap, although has been reluctant to step in 
and provide drugs without an exit strategy.  End Summary. 
 
Current State of TB in Burma 
---------------------------- 
 
2.  (SBU)  Tuberculosis (TB) is a major public health concern in 
Burma and the WHO classifies Burma as one of 22 TB high-burden 
countries in the world.  While the true prevalence of TB in Burma 
remains unknown, the WHO estimates that more than 40 percent of 
Burma's population is infected with TB.  Some NGOs contend that up 
to 60 percent of the population could be infected (Ref B).  The 
Ministry of Health plans to conduct a National TB Prevalence study 
in 2008, although it lacks the $500,000 needed to do so.  Multiple 
drug resistant (MDR-TB) and extensively drug resistant (XDR-TB) TB 
rates are another concern - 2003 WHO studies proved that Burma had 
the highest rate of MDR-TB in Southeast Asia, with 4 percent of new 
cases and 15.5 percent of previously treated TB cases testing 
positive for MDR-TB.  The National TB Reference Lab in Rangoon is 
currently conducting a new drug resistance prevalence study. 
Results should be available in late 2008, although Dr. Ti Ti, 
Director of the National Reference Lab, predicted that the incidence 
rate of MDR-TB is likely to be substantially higher than 2003 
figures. 
 
Public-Private Partnership 
-------------------------- 
 
3.  (SBU)  Through its National TB Program (NTP), which is active in 
all 324 townships in Burma, the Burmese Government seeks to treat 
and prevent TB throughout the country.  The State and Division 
 
RANGOON 00000279  002.2 OF 004 
 
 
Health Departments are responsible for planning, coordination, 
training and technical support, and monitoring of health services on 
the state and division levels.  According to NTP Director Dr. Win 
Maung, township-level TB officers provide the actual health services 
to the people, including dispensing free TB drugs to patients and 
monitoring the patient's treatment.  In 2006, the NTP had a case 
detection rate of 95 percent of all infectious cases and a treatment 
rate of 83.6 percent in 2006, which exceeded WHO targets for 
combating TB.  Burma also has two TB hospitals, Aung San Hospital in 
Rangoon and Pathengyi Hospital in Mandalay, that provide treatment 
for the more challenging TB cases, including MDR and HIV/TB 
co-infection cases. 
 
4.  (SBU)  NTP activities are supplemented by services provided by 
private clinics, including those run by Population Services 
International (PSI), the Myanmar Medical Association, and Medecins 
Sans Frontieres-Holland (MSF-H).  PSI has clinics throughout the 
country, with 415 private doctors providing TB Directly Observed 
Short Course (DOTS) treatment in 100 townships.  MSF-H runs 24 
full-service medical facilities in six states and divisions, and MMA 
has 526 doctors providing DOTS treatment in 23 townships throughout 
the country.  Not all of these clinics provide the same services, 
although all will see and diagnosis TB patients.  PSI clinics treat 
TB patients directly, providing free TB drugs to patients, as well 
as conducting monitoring to ensure that patients complete the TB 
treatment protocol.  MMA clinics refer TB patients to local NTP 
clinics for treatment.  MSF-Holland also refers basic TB cases to 
the NTP, but will treat more difficult TB cases, specifically TB/HIV 
co-infection cases. 
 
5.  (SBU)  TB treatment in both the NTP and in private clinics 
follows the Directly Observed Treatment Short Course (DOTS).  Under 
the DOTS program, which was established with WHO assistance in 1994, 
a community or health care worker directly observes the patient 
swallowing their anti-TB medications over a six month period.  The 
NTP provides TB drugs (provided by Global Drug Facility) to both 
public and private clinics and requires that clinics keep detailed 
accounts of treatment for each patient.  Clinic doctors either 
monitor the patients directly or work with community volunteers and 
family members to ensure that the patients follow the treatment 
protocol. 
 
Securing Access to TB Drugs 
--------------------------- 
 
6. (SBU)  The backbone of Burma's TB program is the free drugs 
provided to TB patients.  The Global Drug Facility (GDF) currently 
is committed to providing first line TB drugs to Burma through the 
end of 2009.  The NTP each year receives DOTS protocol treatment for 
 
RANGOON 00000279  003.2 OF 004 
 
 
approximately 150,000 TB patients and distributes them through the 
NTP and PSI/MSF-H clinical sites.  The drugs are worth an estimated 
$4 million a year.  As the GDF commitment comes to an end, the 
Ministry of Health, WHO, and the private sector are scrambling to 
secure TB drugs for future years (Ref A).  The Burmese Government is 
unwilling to purchase these drugs directly, and the Ministry of 
Health, with its annual TB budget of $400,000 in FY2008, is unable 
to reallocate funding for first-line TB drugs. 
 
7.  (SBU)  Instead, the Ministry of Health is looking toward 
alternate providers of TB drugs, namely the Global Fund. 
Representatives from the Global Fund met with the Minister of Health 
in late March and encouraged him to submit a new application to the 
Global Fund, 3 Diseases Fund Manager Mikko Lainejoki told us.  While 
the senior generals are leery of the Global Fund after its abrupt 
departure from Burma in 2005, MOH officials told the 3D Fund and WHO 
representatives that the Burmese Government was considering 
submitting an application for Round 9, which would begin in 2011. 
However, even if the GOB secured a commitment from the Global Fund 
to cover first line TB drugs, there would still be a two-year gap in 
drug coverage.  This gap could create a dangerous situation in 
Burma, WHO Tuberculosis Officer Dr. Hans Kluge underscored.  The 
rate of TB infection would increase dramatically and people would be 
forced to buy inferior TB drugs on the local market.  If people do 
not complete the TB treatment and stop taking the drugs the minute 
they feel better, they could develop and spread MDR-TB, he stated. 
 
Filling the Gap 
--------------- 
 
8.  (SBU)  Recognizing the lack of TB drugs could pose both a 
domestic and regional problem, the Japanese Government is 
considering providing funds to cover the gap.  Masashi Ogawa, 
Economic Counselor at the Japanese Embassy, warned us that the 
Government of Japan support was not a forgone conclusion because 
relations between Japan and Burma cooled considerably after the 
shooting of the Japanese reporter in September.  The Japanese 
Government plans to reduce humanitarian assistance to Burma by 
one-third in 2008, so funding TB drugs may be politically 
challenging, he underscored.  If the Government of Japan agreed to 
provide TB drugs, it would only be for a few years, rather than long 
term.  Ideally, Japan would provide approximately $4 million in 
funding for 2010 after the Burmese Government agreed to apply for 
Round 9 of the Global Fund.  The last thing Japan wants is to start 
funding the program with no exit strategy, Ogawa stated. 
 
9.  (SBU)  During our two-week assessment of Burma's current TB 
situation, we found that most donors were confident that the 
Japanese would provide funding to cover the gap period, although 
 
RANGOON 00000279  004.2 OF 004 
 
 
they understood the political challenges facing the Japanese 
Government.  In the meantime, the WHO plans to encourage the GDF to 
extend its program an additional year, although Dr. Kluge told us 
that this was unlikely because the GDF had already extended its 
program in Burma by one year.  While some NGOs mentioned that the 3D 
Fund may shift resources to cover drugs, 3D Fund TB Officer Atila 
Molnar stressed that the 3D Fund did not have enough funds to cover 
the gap.  Additionally, the 3D Fund's mandate is to strengthen 
health care services at the township level; he doubted the 3D Fund 
Board would agree to divert resources from the local level to cover 
the cost of TB drugs.  There are only two options, Molnar declared: 
either the Japanese Government covers the gap period or the Burmese 
Government puts additional resources toward procuring drugs.  Since 
the second option is unlikely, he stated, donors will continue to 
pressure the Japanese to fill the gap. 
 
Comment 
------- 
 
10. (SBU)  During USAID's two-week assessment of Burma's TB program, 
we learned that the NTP faces many challenges in combating and 
preventing the spread of TB both inside and outside of Burma (Ref 
A).  However, officials from the Ministry of Health, NTP, 3D Fund, 
WHO, and NGOs all agreed that the most immediate challenge facing 
both the public and private sector is securing access to first-line 
TB drugs after 2009.  A solid first-line drug regimen is the 
backbone of Burma's TB program and is vital to preventing the spread 
of TB, including multi-drug and extensively drug resistant TB. 
Certainly, the Burmese military regime, with more than $2 billion in 
annual oil revenues, should be funding these, but it won't. 
Therefore, we should encourage the Japanese Government, the only 
donor who is able to procure drugs, to fund Burma's first-line TB 
regime for 2010 and beyond.  Once long-term access to drugs is 
secured, the NTP and the private sector can begin to address other 
challenges, including strengthening case detection and treatment, 
building capacity at the national labs, and improving infection 
control. 
 
VILLAROSA